Although multiple mechanisms have been postulated, peripartum cardiomyopathy (PPCM) continues to be a cardiomyopathy of unknown cause. Multiple risk factors exist and the clinical presentation does not allow differentiation among potential causes. Although specific diagnostic criteria exist, PPCM remains a diagnosis of exclusion. Treatment modalities are dictated by the clinical state of the pa...

Peripartum cardiomyopathy is a form of heart failure caused by depression of left ventricular systolic function that occurs in healthy women during pregnancy or within a few months postpartum and can have devastating consequences, both physically and mentally. Although this condition may deteriorate and result in a need for heart transplantation or even death, the majority of patients demonstra...

The clinical course of a patient with peripartum cardiomyopathy and hyperprolactinaemia is described. Hyperprolactinaemia may be a factor in this patient's heart failure.

Severe maternal thrombocytopenia resulting in hemorrhage is often associated with high mortality. Three cases of severe maternal thrombocytopenia in association with heparin-induced thrombocytopenia (HIT), HELLP syndrome, and systemic lupus erythematosus (SLE) were successfully managed using intravenous immunoglobulin (IVIG). IVIG can reduce the severity of thrombocytopenia and hemolysis, stabi...

This retrospective cohort study aimed to explore the relationship between temporal changes in cardiac function and peripartum events pregnant women with low-risk congenital heart disease.